Anheuser-Busch InBev is partnering with Tilray, a Canadian marijuana grower, to research nonalcoholic beverages laced with the drug. The agreement is limited to the Canadian market, and each company
is investing $50 million. It is not the first beer maker to jump onboard the weed train. Corona brewer Constellation Brands is investing $4 billion in Canadian grower Canopy Growth, and Molson Coors
formed a joint venture with Canada’s Hydropothecary.
Read the whole story at Wall Street Journal »
